Eyeworld

86 | EYEWORLD | APRIL 2023 G UCOMA by Manjool Shah, MD Glaucoma Editor W e recently had the unique opportunity to chaotically pack up our four dogs, seven cats, two birds, and the house they all shared with me and my wife as we moved from Ann Arbor, Michigan to the New York metro area. After 7 fantastic years on faculty at the Kellogg Eye Center at the Univer- sity of Michigan, I was given an opportunity to join the Glaucoma Division of Langone Eye Center at New York University. I cannot put into words the gratitude I feel toward my wife and our family for putting up with all of this. I am also incredibly thankful for the patients and colleagues I worked with during my years in Ann Arbor. As I build a new practice at New York University, the differences and similarities between my new patients and my old ones are fascinating. Generalization is impossible, but if my relocation has taught me anything, it's that there are some common themes that all patients want and need. All of our patients need providers they can trust to help them navigate the increasingly complex set of diagnostic and therapeutic challenges in the management of glaucoma. It is important to remain humble even though our interventional toolkit has got- ten safer, for glaucoma is still a frightening diag- nosis for many patients. That being said, the era of individualized, nuanced, patient-centric care is here, and patients everywhere deserve access to the best this paradigm shift can provide. In this issue, Deborah Ristvedt, DO, and Steven R. Sarkisian Jr., MD, share their thoughts on IOL selection for glaucoma patients. Empha- sizing an individualized approach, both doctors describe ways in which the newest IOL and MIGS technologies can be leveraged to optimize patient quality of life. Sameh Mosaed, MD, Arsham Sheybani, MD, and Kuldev Singh, MD, discuss IOP reduction and achievable targets with MIGS vs. traditional glaucoma surgery. While MIGS procedures may not achieve the magnitude of IOP reduction compared to traditional procedures, our goals have evolved beyond just millimeters of mer- cury. Reducing medication burden and diurnal fluctuations may point to better long-term stabilization of disease in the right patient, but ultimately patient selection and tailoring care for each disease type and severity is paramount. Mona Kaleem, MD, Omar Mohiuddin, OTR/L, CLVT, and Jullia Rosdahl, MD, PhD, share their insights on visual aids and vision rehabilitation for glaucoma patients. Again, we see the common themes of individualization based on patient need and disease severity, and the necessity to harness technology to provide that level of customization. As we approach the 2023 ASCRS Annu- al Meeting, look for all the ways our ability to take care of glaucoma patients has grown and evolved. ASCRS has a long track record of challenging orthodoxy and dogma, creating a safe and fertile space for connections to be made and boundaries to be transcended. As is evident in the multitude of symposia, wet labs, and the ever-popular Glaucoma Day, interven- tional glaucoma is no longer the sole purview of the glaucoma subspecialist. To the contrary, the family of glaucoma care providers has grown tremendously. Thanks to the bridges that have been built among the glaucoma, cornea, cata- ract, and refractive communities, venues like the ASCRS Annual Meeting show us how we can leverage our various skillsets to provide the best possible care for our patients. It's a privilege to learn alongside all of you while showcasing the amazing talent, technolo- gy, and innovation in our field, and an honor to take over as Glaucoma Editor. EyeWorld and ASCRS have been outstanding partners in broadcasting the revolution in our field, and I am so proud to join the family. I also want to acknowledge our outstanding Editorial Board and offer a warm welcome to the newest mem- bers of the glaucoma crew, Lori Provencher, MD, Mark Gallardo, MD, and Mary Qiu, MD. Let me also take a moment to thank my friend, colleague, and mentor Nathan Radcliffe, MD, on his stewardship of this position for the past 5 years. I promise to do my utmost to live up to the high standards Nate has set for the Glau- coma section and appreciate your feedback on ways to make the section the best it can be. See you all in San Diego! An era of individualized, patient-centric care

• Blank Page
• Blank Page (1)